Related Experiment Video

Updated: May 11, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Signal transduction in human cutaneous melanoma and target drugs

Anatoly B Uzdensky1, Svetlana V Demyanenko, Mikhail Y Bibov

  • 1194/1 Stachky ave., NII NK, Rostov-on-Don, 344090, Russia. auzd@yandex.ru.

Current Cancer Drug Targets
|May 17, 2013
PubMed

Insights

Malignant melanoma arises from complex signaling pathway changes affecting cell growth and survival. Targeting these pathways offers promising new therapeutic strategies for this aggressive cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • Malignant melanoma is an aggressive, metastatic cancer resistant to conventional treatments.
  • Understanding melanoma's underlying molecular mechanisms is crucial for developing effective therapies.
  • Melanoma development involves intricate alterations in signaling pathways controlling cell proliferation and apoptosis.

Purpose of the Study:

  • To review current data on signaling pathways involved in human cutaneous melanoma development.
  • To highlight the role of these pathways in cell cycle regulation and apoptosis evasion.
  • To discuss the potential of targeting these pathways for melanoma treatment.

Main Methods:

  • Literature review of current scientific data on melanoma signaling pathways.
  • Analysis of pathways including cyclin/CDK, Ras/Raf/MEK/MAPK, PI3K/Akt/PTEN/mTOR, and others.
  • Examination of growth factor involvement in melanoma pathogenesis.

Main Results:

  • Multiple signaling pathways (e.g., Ras/Raf/MEK/MAPK, PI3K/Akt/PTEN/mTOR, Wnt/β-catenin) are implicated in melanoma genesis and progression.
  • Dysregulation of these pathways contributes to uncontrolled cell proliferation and resistance to cell death.
  • Specific pathways like MITF and Jak/STAT also play significant roles.

Conclusions:

  • Understanding molecular aberrations in melanoma oncogenesis is key for improved diagnosis and prognosis.
  • Targeted inhibitors of these signaling pathways represent a promising strategy for anti-melanoma therapy.
  • Novel targeted drugs are being developed based on these molecular insights.

More Related Videos

The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression11:02

The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression

Published on: August 3, 2011

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...